KLH-conjugated synthetic peptide encompassing a sequence within human Cytokeratin 17. The exact sequence is proprietary.
Conjugation:
Unconjugated
Alternative Names:
Keratin type I cytoskeletal 17, 39.1, Cytokeratin-17, CK-17, Keratin-17, K17
Keratins (cytokeratins) are intermediate filament proteins that are mainly expressed in epithelial cells. Keratin heterodimers composed of an acidic keratin (or type I keratin, keratins 9 to 23) and a basic keratin (or type II keratin, keratins 1 to 8) assemble to form filaments. Keratin isoforms demonstrate tissue- and differentiation-specific profiles that make them useful as research biomarkers. Research studies have shown that mutations in keratin genes are associated with skin disorders, liver and pancreatic diseases, and inflammatory intestinal diseases. Keratin 17 is involved in wound healing and cell growth, two processes that require rapid cytoskeletal remodeling. Keratinocytes deficient in keratin 17 exhibit abnormal Akt/mTOR signaling and fail to produce an increase in translation, cell size, or growth, these cells also exhibit abnormal 14-3-3sigma localization. As 14-3-3sigma typically associates with keratin 17, these results imply that Akt/mTOR signaling results in sequestration of 14-3-3sigma with keratin 17 in the cytosol, which is required for translation and cell growth. Phosphorylation of keratin 17 on Ser44 may provide a docking site for 14-3-3sigma binding.
The antibody was affinity-purified from mouse antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
Form:
Mouse IgG1. Liquid in PBS containing 50% glycerol, 0.2% BSA and 0.01% sodium azide.
Application Dilute:
WB (1/500 - 1/1000), IHC (1/100 - 1/300)
Application Notes:
Recognizes endogenous levels of Cytokeratin 17 protein.
* VAT and and shipping costs not included. Errors and price changes excepted
